123 related articles for article (PubMed ID: 11124746)
21. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study.
Galluzzi JR; Cupples LA; Meigs JB; Wilson PW; Schaefer EJ; Ordovas JM;
Diabetes Care; 2001 Jul; 24(7):1161-6. PubMed ID: 11423496
[TBL] [Abstract][Full Text] [Related]
22. The Ala54Thr Polymorphism of the Fatty Acid Binding Protein 2 Gene Modulates HDL Cholesterol in Mexican-Americans with Type 2 Diabetes.
Salto LM; Bu L; Beeson WL; Firek A; Cordero-MacIntyre Z; De Leon M
Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010052. PubMed ID: 26703680
[TBL] [Abstract][Full Text] [Related]
23. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells.
Baier LJ; Bogardus C; Sacchettini JC
J Biol Chem; 1996 May; 271(18):10892-6. PubMed ID: 8631905
[TBL] [Abstract][Full Text] [Related]
24. Thr-encoding allele homozygosity at codon 54 of FABP 2 gene may be associated with impaired delta 6 desatruase activity and reduced plasma arachidonic acid in obese children.
Okada T; Sato NF; Kuromori Y; Miyashita M; Iwata F; Hara M; Harada K; Hattori H
J Atheroscler Thromb; 2006 Aug; 13(4):192-6. PubMed ID: 16908951
[TBL] [Abstract][Full Text] [Related]
25. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes.
Georgopoulos A; Aras O; Tsai MY
J Clin Endocrinol Metab; 2000 Sep; 85(9):3155-60. PubMed ID: 10999802
[TBL] [Abstract][Full Text] [Related]
26. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects.
Hayakawa T; Nagai Y; Nohara E; Yamashita H; Takamura T; Abe T; Nomura G; Kobayashi K
Metabolism; 1999 May; 48(5):655-7. PubMed ID: 10337870
[TBL] [Abstract][Full Text] [Related]
27. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R
Ann Nutr Metab; 2006; 50(4):354-60. PubMed ID: 16809903
[TBL] [Abstract][Full Text] [Related]
28. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans.
Nakanishi S; Yamane K; Kamei N; Okubo M; Kohno N
Diabetes Obes Metab; 2004 Jan; 6(1):45-9. PubMed ID: 14686962
[TBL] [Abstract][Full Text] [Related]
29. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat.
Marín C; Pérez-Jiménez F; Gómez P; Delgado J; Paniagua JA; Lozano A; Cortés B; Jiménez-Gómez Y; Gómez MJ; López-Miranda J
Am J Clin Nutr; 2005 Jul; 82(1):196-200. PubMed ID: 16002819
[TBL] [Abstract][Full Text] [Related]
30. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene.
Georgopoulos A; Aras O; Noutsou M; Tsai MY
J Clin Endocrinol Metab; 2002 Aug; 87(8):3735-9. PubMed ID: 12161503
[TBL] [Abstract][Full Text] [Related]
31. Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men.
Ishii T; Hirose H; Kawai T; Hayashi K; Maruyama H; Saito I; Saruta T
Metabolism; 2001 Nov; 50(11):1301-7. PubMed ID: 11699048
[TBL] [Abstract][Full Text] [Related]
32. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2.
De Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; De la Fuente B
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):89-95. PubMed ID: 20329566
[TBL] [Abstract][Full Text] [Related]
33. The association of Ala54Thr variant of intestinal fatty acid binding protein gene with general and regional adipose tissue depots.
Kunsan X; Taisan Z; Weiping J; Duoqi S; Wei D; Jie L; Junxi L; Rong Z
Chin Med Sci J; 1999 Mar; 14(1):46-51. PubMed ID: 12899384
[TBL] [Abstract][Full Text] [Related]
34. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM.
Saarinen L; Pulkkinen A; Kareinen A; Heikkinen S; Lehto S; Laakso M
Diabetes Care; 1998 May; 21(5):849-50. PubMed ID: 9589253
[TBL] [Abstract][Full Text] [Related]
35. No association found between the Ala54Thr polymorphism of FABP2 gene and obesity and obesity with dyslipidemia in Japanese schoolchildren.
Endo K; Yanagi H; Hirano C; Hayakawa Y; Hamaguchi H; Tomura S
J Atheroscler Thromb; 2001; 8(3):80-3. PubMed ID: 11866034
[TBL] [Abstract][Full Text] [Related]
36. Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
Chamberlain AM; Schreiner PJ; Fornage M; Loria CM; Siscovick D; Boerwinkle E
Metabolism; 2009 Sep; 58(9):1222-8. PubMed ID: 19439328
[TBL] [Abstract][Full Text] [Related]
37. [FABP2 gene polymorphism and metabolic disorder of lipids in the middle aged and aged population].
Liu Y; Zhai C; Cao P; Zheng Y; Zhou S; Chi J
Wei Sheng Yan Jiu; 2011 Jul; 40(4):461-4. PubMed ID: 21861348
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.
Gomez LC; Real SM; Ojeda MS; Gimenez S; Mayorga LS; Roqué M
BMC Med Genet; 2007 Jun; 8():39. PubMed ID: 17594477
[TBL] [Abstract][Full Text] [Related]
39. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors.
de Luis DA; Sagrado MG; Aller R; Izaola O; Conde R
Horm Metab Res; 2007 Nov; 39(11):830-4. PubMed ID: 17992640
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
J Endocrinol Invest; 2013 Jun; 36(6):402-6. PubMed ID: 23817228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
